Metagenomic Sequencing Market Report 2026

Metagenomic Sequencing Market Overview

• Metagenomic Sequencing market size has reached to $2.5 billion in 2025 • Expected to grow to $5.14 billion in 2030 at a compound annual growth rate (CAGR) of 15.1% • Growth Driver: Rising Prevalence Of Infectious Diseases Fuels Growth In The Metagenomic Sequencing Market • Market Trend: Metagenomic Sequencing Companies Drive Innovation With Advanced Long-Read Sequencing Services • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Metagenomic Sequencing Market?

Metagenomic sequencing is a technique used to analyze the genetic material from an entire community of microorganisms found in a specific environment, without the need for culturing individual species. The method involves the extraction of DNA directly from environmental samples, such as soil, water, or the human gut. The extracted DNA is then sequenced using high-throughput sequencing technologies. The main products and services of the metagenomic sequencing market are reagents and consumables, instruments, sequencing services, and analysis and data interpretation solutions. Reagents and consumables refer to the chemical substances, kits, and disposable items used during laboratory experiments and procedures. The various technologies include 16s rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing and de novo assembly, and metatranscriptomics used in various applications such as clinical diagnostic, environmental remediation, gut microbe characterization, drug discovery, biofuel, agriculture, and other applications.

What Is The Metagenomic Sequencing Market Growth Forecast?

The metagenomic sequencing market size is expected to see rapid growth in the next few years. It will grow to $5.14 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to advancements in sequencing technologies, growth in microbiome-based therapeutics, increasing investment in bioinformatics, rising demand for cloud-based genomic analysis, expansion of precision medicine applications. Major trends in the forecast period include precision genomics expansion through high-throughput sequencing, AI-driven metagenomic data analysis, automation of sample preparation and sequencing workflows, cloud-based bioinformatics platforms for big data handling, iot-enabled environmental microbiome monitoring.

Global Metagenomic Sequencing Market Segmentation

1) By Product And Service: Reagents And Consumables, Instruments, Sequencing Services, Analysis And Data Interpretation Solutions 2) By Technology: 16S RNA Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing And De Novo Assembly, Metatranscriptomics 3) By Application: Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Other Applications Subsegments: 1) By Reagents And Consumables: DNA Or RNA Extraction Kits, Library Preparation Kits, Sequencing Kits, PCR And qPCR Reagents, Other Consumables (Buffers, Probes) 2) By Instruments: Next-Generation Sequencers (NGS), Third-Party Sequencers, Microarrays, Real-Time PCR Instruments 3) By Sequencing Services: Whole Genome Sequencing (WGS), 16S rRNA Sequencing, Shotgun Metagenomic Sequencing, Amplicon Sequencing, Metatranscriptomic Sequencing 4) By Analysis And Data Interpretation Solutions: Bioinformatics Software, Cloud-Based Data Analysis Services, Data Storage Solutions, Custom Analysis Tools, Data Interpretation Platforms

What Is The Driver Of The Metagenomic Sequencing Market?

The rising burden of tuberculosis (TB) is expected to propel the growth of the metagenomic sequencing market going forward. Tuberculosis is a contagious infectious disease caused by Mycobacterium tuberculosis, primarily affecting the lungs and spreading through airborne droplets when infected individuals cough or sneeze. TB cases are increasing due to factors such as global migration, weakened immune systems, antimicrobial resistance, and gaps in public health surveillance. Metagenomic sequencing supports TB detection by enabling rapid, unbiased identification of pathogens, detection of drug-resistance genes, and improved outbreak tracking, critical for managing evolving infectious threats. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the rising burden of tuberculosis is driving the growth of the metagenomic sequencing industry.

Key Players In The Global Metagenomic Sequencing Market

Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH

Global Metagenomic Sequencing Market Trends and Insights

Major companies operating in the metagenomic sequencing market are focusing on innovating sequencing services, to improve sequencing accuracy, throughput, and cost-effectiveness. Sequencing services refer to cutting-edge genomic technologies that enable the sequencing of longer DNA fragments, providing a more comprehensive view of genetic structures compared to traditional short-read methods. For instance, in April 2024, Clinical Microbiomics A/S, a Denmark-based biotechnology company, launched advanced long-read sequencing services, including 16S, ITS, 18S rRNA, custom gene sequencing, and comprehensive genomics and metagenomics, which provide unparalleled resolution and quality in microbial analysis, enabling detailed insights into microbial communities and facilitating the creation of high-quality metagenome-assembled genomes.

What Are Latest Mergers And Acquisitions In The Metagenomic Sequencing Market?

In March 2024, Clinical Microbiomics A/S, a Denmark-based healthcare and biotechnology contract-research-organisation focused on microbiome and multi-omics services, acquired DNASense ApS for an undisclosed amount. With this acquisition, Clinical Microbiomics expanded its technological capabilities by adding long-read DNA & RNA sequencing and advanced bioinformatics for enhanced metagenomic and multi-omics analyses. DNASense ApS is a Denmark-based biotechnology company specializing in long-read DNA and RNA sequencing technologies and bioinformatics services for microbial community (metagenomic) analysis, environmental, industrial, and microbiome-related applications.

Regional Outlook

North America was the largest region in the metagenomic sequencing market in 2025. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Metagenomic Sequencing Market?

The metagenomic sequencing market includes revenues earned by entities by providing services such as sample preparation, sequencing, metagenomic profiling, and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The metagenomic sequencing market also includes sales of sequencing platforms, bioinformatics software, DNA extraction kits, and sequencing reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Metagenomic Sequencing Market Report 2026?

The metagenomic sequencing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomic sequencing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.